Dietary lactitol fermentation increases circulating peptide YY and glucagon-like peptide-1 in rats and humans.

[1]  A. Young,et al.  Effects of PYY[3–36] in rodent models of diabetes and obesity , 2004, International Journal of Obesity.

[2]  L. B. Knudsen.  Glucagon-like peptide-1: the basis of a new class of treatment for type 2 diabetes. , 2004, Journal of medicinal chemistry.

[3]  R. Cone,et al.  Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism. , 2004, Endocrinology.

[4]  P. Tso,et al.  Ingested fat and satiety , 2004, Physiology & Behavior.

[5]  J. Halford,et al.  The pharmacology of human appetite expression. , 2004, Current drug targets.

[6]  J. Holst,et al.  Gastric emptying, gastric secretion and enterogastrone response after administration of milk proteins or their peptide hydrolysates in humans , 2004, European journal of nutrition.

[7]  S. O’Rahilly,et al.  Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse. , 2003, Biochemical and biophysical research communications.

[8]  Mohammad A Ghatei,et al.  Inhibition of food intake in obese subjects by peptide YY3-36. , 2003, The New England journal of medicine.

[9]  P. J. Larsen,et al.  Central pre-proglucagon derived peptides: opportunities for treatment of obesity. , 2003, Current pharmaceutical design.

[10]  D. Drucker.  Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. , 2003, Molecular endocrinology.

[11]  M. McBurney,et al.  The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal , 2003, European Journal of Clinical Nutrition.

[12]  Rachel L. Batterham,et al.  Gut hormone PYY3-36 physiologically inhibits food intake , 2002, Nature.

[13]  R. Zabielski,et al.  Multiple regulation of peptide YY secretion in the digestive tract , 2002, Peptides.

[14]  F. Sundler,et al.  Distribution of pancreatic polypeptide and peptide YY , 2002, Peptides.

[15]  D. Drucker.  Biological actions and therapeutic potential of the glucagon-like peptides. , 2002, Gastroenterology.

[16]  P. J. Larsen,et al.  Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats. , 2001, Diabetes.

[17]  D. Drucker,et al.  Minireview: the glucagon-like peptides. , 2001, Endocrinology.

[18]  C. Malbert,et al.  Ileal short-chain fatty acids inhibit gastric motility by a humoral pathway. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[19]  J. Habener,et al.  The glucagon-like peptides. , 1999, Endocrine reviews.

[20]  J. Holst,et al.  Importance of Colonic Bacterial Fermentation in Short Bowel Patients (Small Intestinal Malabsorption of Easily Digestible Carbohydrate) , 1999, Digestive Diseases and Sciences.

[21]  S. Hampton,et al.  The influence of the colon on postprandial glucagon-like peptide 1 (7-36) amide concentration in man. , 1999, The Journal of endocrinology.

[22]  G. Frost,et al.  Effect of large bowel fermentation on insulin, glucose, free fatty acids, and glucagon-like peptide 1 (7-36) amide in patients with coronary heart disease. , 1999, Nutrition.

[23]  J. Galmiche,et al.  Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[24]  R. Goodlad,et al.  Fermentable dietary fibre, intestinal microflora and plasma hormones in the rat. , 1997, Clinical science.

[25]  M. McBurney,et al.  Dietary fiber modulates intestinal proglucagon messenger ribonucleic acid and postprandial secretion of glucagon-like peptide-1 and insulin in rats. , 1996, Endocrinology.

[26]  J. Holst,et al.  Colonic fermentation and proximal gastric tone in humans. , 1996, Gastroenterology.

[27]  I. Johnson,et al.  Fermentable carbohydrate modulates postprandial enteroglucagon and gastrin release in rats , 1996, British Journal of Nutrition.

[28]  J. Galmiche,et al.  Peptide YY release after intraduodenal, intraileal, and intracolonic administration of nutrients in rats , 1995, Pflügers Archiv.

[29]  N. Read,et al.  The Effect on Hunger and Satiety of Slowing the Absorption of Glucose: Relationship with Gastric Emptying and Postprandial Blood Glucose and Insulin Responses , 1995, Appetite.

[30]  T. Adrian,et al.  Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon. , 1993, Gut.

[31]  J M Polak,et al.  Human distribution and release of a putative new gut hormone, peptide YY. , 1985, Gastroenterology.

[32]  T. Hökfelt,et al.  Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[33]  I. Johnson,et al.  Influence of viscous incubation media on the resistance to diffusion of the intestinal unstirred water layer in vitro , 1982, Pflügers Archiv.

[34]  J. Egan,et al.  Glucagon-like peptide-1. , 2001, Recent progress in hormone research.

[35]  D. Larhammar,et al.  Neuropeptide Y family of peptides: structure, anatomical expression, function, and molecular evolution. , 2000, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[36]  M. McBurney,et al.  Nutrient Requirements and Interactions Fermentable Dietary Fiber Increases GLP-1 Secretion and Improves Glucose Homeostasis Despite Increased Intestinal Glucose Transport Capacity in Healthy Dogs , 1998 .